STERIS plc Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
STERIS plc (STE) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $230.74 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-07
- STERIS plc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-06-30 was $230.74, a 13.79% decline year-over-year.
- STERIS plc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-06-30 was $267.66, a 6.49% increase year-over-year.
- STERIS plc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-06-30 was $251.35, a 14.27% increase year-over-year.
- STERIS plc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-06-30 was $219.97, a 12.03% decline year-over-year.
- STERIS plc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2026 was $265.21, a 5.76% increase from fiscal 2025.
- STERIS plc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $250.76, a 13.86% increase from fiscal 2024.
- STERIS plc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $220.24, a 11.00% decline from fiscal 2023.
- STERIS plc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $247.45, a 15.04% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $230.74 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $265.21 10-K · filed 2026-05-29 | |||
| 2025-12-31 | $266.29 10-Q · filed 2026-02-06 | |||
| 2025-09-30 | $266.33 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $267.66 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $250.76 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $250.76 10-Q · filed 2025-02-07 | |||
| 2024-09-30 | $250.76 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $251.35 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $220.24 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $220.24 10-Q · filed 2024-02-08 | |||
| 2023-09-30 | $220.24 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $219.97 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $247.45 10-K · filed 2023-05-26 | |||
| 2022-12-31 | $247.45 10-Q · filed 2023-02-08 | |||
| 2022-09-30 | $247.45 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $250.06 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | $215.10 10-K · filed 2022-05-31 | |||
| 2021-12-31 | $215.10 10-Q · filed 2022-02-09 | |||
| 2021-09-30 | $210.79 10-Q · filed 2021-11-08 | |||
| 2021-06-30 | $210.31 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $181.33 10-K · filed 2021-05-28 | |||
| 2020-12-31 | $181.33 10-Q · filed 2021-02-09 | |||
| 2020-09-30 | $181.33 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | $182.22 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | $147.22 8-K · filed 2021-02-09 | |||
| 2019-12-31 | $147.22 10-Q · filed 2020-02-10 | |||
| 2019-09-30 | $147.22 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | $147.05 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | $114.49 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |